Indium (111In) biciromab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Indium (111In) biciromab
Monoclonal antibody
Type Fab' fragment
Source Mouse
Target Fibrin II, beta chain
Clinical data
Trade names FibriScint
  • N/A
ATC code
  • none
Legal status
Legal status
  • Withdrawn
CAS Number
  • none
 NYesY (what is this?)  (verify)

Indium (111In) biciromab (INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood.[1] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism,[2] but was withdrawn during clinical trials.[3]


  1. ^ King, David J.; John R. Adair (1999). "Recombinant antibodies for the diagnosis and therapy of human disease". Current Opinion in Drug Discovery & Development. 2 (2): 112. ISSN 1367-6733. 
  2. ^ Centocor Ortho Biotech Products, L.P.
  3. ^ Centocor withdraws imaging agent applications